10 Billion Reasons To Own This Recession-Proof Stock
With concerns of an impending recession looming large and Goldman Sachs pivoting away from momentum stocks to value stocks, one stock that may fit the bill is Procter & Gamble.
Although the share price has been somewhat volatile subsequent to fiscal Q4 2024 earnings results, P&G bounced back nicely to make an assault on all-time highs. » Read more about: 10 Billion Reasons To Own This Recession-Proof Stock »
Read More
1 Growth Stock Down 30% You’ll Regret Not Buying The Dip
DigitalOcean is no ordinary cloud computing firm as you’ll see but it is down by 30% over the past 6 months, and yet appears to have significant upside potential from here.
If you’re not familiar with it, the company is like AWS or Google Cloud, but for small to medium-sized businesses (SMBs). Developers like it because of its…
Read More
Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
Read More
Market Commentary: Is This 7.9% Dividend Real?
In my view, Verizon’s generous dividend isn’t just stable, it’s on track to climb even higher. As it stands, Verizon offers a tantalizing dividend yield of 7.9%, a figure amplified by the recent dip in its stock price. The stock has lost about a fifth of its value from its peak over the past 52 weeks,
» Read more about: Market Commentary: Is This 7.9% Dividend Real? »
Read More
1 Growth Stock Down Over 85% to Buy Now
Roku Inc. (NASDAQ: ROKU) seems like a stock to run from at first glance. With shares down by over 85% since the heady days of 2021 and profits still to be delivered, it’s hard to make a strong case for the company as a good investment.
But a deeper dive reveals some compelling reasons to pay attention to this former high flyer.
» Read more about: 1 Growth Stock Down Over 85% to Buy Now »
Read MoreThe Burst
Buffett’s Billion Dollar Bet Is a Halloween Treat
It’s not every day that Warren Buffett bets big on a bank outside the United States, but his latest move suggests he sees something special in one international fintech company.
The stock, relatively unknown compared to Buffett’s flagship investments like Coca-Cola or Apple, serves millions across Latin America and is elbowing into our out,
» Read more about: Buffett’s Billion Dollar Bet Is a Halloween Treat »
Read MoreThe Ivy
Is Your Favorite Pharmacy About To Go Belly Up?
Walgreens Boots Alliance stands at a critical juncture in the company’s 170-year history with revenues of $147 billion but a market capitalization of just $7 billion.
A heavily burdened balance sheet has been the prime culprit of the stock’s downfall but, under new CEO Tim Wentworth, management is undertaking an ambitious realignment aimed at stabilizing the core pharmacy business while taking the chop to some of its healthcare investments.
» Read more about: Is Your Favorite Pharmacy About To Go Belly Up? »
Read MoreThe Daily
Will Donald Trump Heed Warren Buffett's Stark Warning About Tariffs?
A billionaire will again occupy the Oval Office once Donald Trump is sworn in as president on Monday. Several billionaires will likely be there to watch the inauguration, including Amazon founder and Chairman Jeff Bezos, Tesla CEO Elon Musk, and Meta Platforms founder and CEO Mark Zuckerberg.
Another prominent billionaire won’t attend Trump’s big day —
» Read more about: Will Donald Trump Heed Warren Buffett's Stark Warning About Tariffs? »